Michael Monostra

NEW ORLEANS — Fewer than half of children and adolescents with type 2 diabetes are prescribed GLP-1 receptor agonists at most pediatric diabetes

PHILADELPHIA — Health care professionals should use the full spectrum of continuous glucose monitoring metrics to assess complication risk for people with diabetes, according to a speaker at the Heart in Diabetes CME Conference.

NEW ORLEANS — Even with all the advances in technology, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP said patients remain at the center of diabetes management.

PHILADELPHIA — Body composition and obesity-related complications differ between men and women , but incretin-based medications confer benefits among all adults, according to a speaker at the Heart in Diabetes CME Conference.

NEW ORLEANS — Adults with type 2 diabetes who were provided medically tailored healthy meals and lifestyle counseling for 6 months had a lower HbA1c than those who received a monthly food subsidy, researchers reported.

NEW ORLEANS — Adults with type 1 diabetes had a similar time in range using automated insulin delivery with ultrarapid-acting insulin lispro-aabc and pramlintide compared with insulin lispro-aabc alone, according to a speaker. In findings from a randomized crossover trial presented at the American Diabetes Association Scientific Sessions, use of a fully closed-loop automated insulin delivery

NEW ORLEANS — Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin delivery system compared with Omnipod 5, according to data from the STRIVE trial.

A once-daily oral medication raised annualized height velocity for children and adolescents with achondroplasia, according to data from a phase 3 trial published in The New England Journal of Medicine

PHILADELPHIA — Most websites selling GLP-1 receptor agonists prescribe medications without any direct interaction with a health care professional, according to data from a “secret shopper” study.

Adults with type 2 diabetes may be more likely to report smell and taste disturbances if they were prescribed a GLP-1 receptor agonist, according to data published in JAMA Otolaryngology – Head & Neck Surgery